Treatment of a genetic liver disease in mice through transient prime editor expression
Tanja Rothgangl(University of Zurich), Gerald Schwank(University of Zurich), Jennifer Moon(Acuitas Therapeutics (Canada)), Kim Fabiano Marquart(University of Zurich), Lukas Schmidheini(University of Zurich), Paulo J.C. Lin(University of British Columbia), Steven H.Y. Fan(Acuitas Therapeutics (Canada)), Johannes Häberle(University Children's Hospital Zurich), Mai Matsushita(ETH Zurich), Nicole Rimann(University Children's Hospital Zurich), Ying K. Tam(Arbutus Biopharma (Canada)), Norbert Pardi(University of Pennsylvania), Alessio Cremonesi(University of Zurich), Beat Thöny(Swiss Integrative Center for Human Health), Yanik Weber(University of Zurich), Hiromi Muramatsu(University of Pennsylvania), András Tálas(University of Zurich), Máté Vadovics(University of Pennsylvania), Erica Faccin(University Children's Hospital Zurich), Manfred Köpf(École Polytechnique Fédérale de Lausanne), Elina Andrea Villiger(University of Zurich), Desirée Böck(University of Zurich), Lukas Villiger(McGovern Institute for Brain Research), Cornelia Schwerdel(University of Zurich), Eleonora Ioannidi(University of Zurich)
Cited by 4
Related Papers
mRNA vaccines — a new era in vaccinology
|Nature Reviews Drug Discovery|2018|4.4k
Rational design of cationic lipids for siRNA delivery
|Nature Biotechnology|2010|1.8k
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
|Nature Nanotechnology|2019|1.6k
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**
|Angewandte Chemie International Edition|2012|1.2k